Long-term administration of IV iron benefits adults with heart failure and iron deficiency

Long-term treatment with iron administered intravenously improved symptoms and reduced recurrent hospitalizations among people with heart failure and iron deficiency, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

Related Keywords

United States ,United Kingdom ,Chicago ,Illinois ,American ,British ,Michele Robertson ,Iainb Squire ,Elizabetha Thomson ,Iainc Macdougall ,Gian Ford ,Emily Henderson ,John Gf Cleland ,Markc Petrie ,Philipa Kalra ,Pierpaolo Pellicori ,Paul Kalra ,British Heart Foundation ,Portsmouth Hospitals University National Health Service ,American Heart Association ,American Heart Association Scientific Sessions ,University Of Glasgow ,Scientific Sessions ,British Heart ,Heart ,Heart Failure ,Iron Deficiency ,Education ,Exercise ,Hospital ,Ortality ,Pandemic ,Research ,